Characteristics of Sub-Saharan African Women Seeking Assisted Reproductive Technique (ART) and Outcomes
Abstract
To describe the features of women seeking assisted reproductive technique (ART) in the Gabonese Republic (sub-Saharan Africa) and investigate In Vitro Fertilization (IVF) success in this sub-Saharan setting. In this retrospective study, we analyzed data of women on their first IVF round from January 1st, 2019, to December 31st, 2020. The Analyzed data included antimullerian hormone (AMH) levels, antral follicle count (AFC), number of mature oocytes collected, myomas, tubal obstruction, partner abnormality in the spermogram, and history of urogenital infection and pelvic surgery. Women seeking assisted reproductive techniques were characterized by a high prevalence of tubal obstructions (73.4%), myomas (39%), and a history of urogenital infection (35.5%). We retrieved a total of 1662 oocytes of which 1439 mature oocytes. The average serum AMH concentration was 2.33(+/-2.71) ng/ml while the average AFC WAS 14.63 (5+/-11.37). In up to 50% of infertile couples, a male factor plays a role. The rate of IVF procedures leading to live birth was 31%. Women who had gynecologic surgery had better odds of giving live birth (2.7 odds; p-value = 0.01). Our study showed that a high and combined burden of fallopian tubal obstructions, urogenital infection, and myomas characterize IVF candidates in Gabonese Republic. Also, the IVF success rate in this setting is close to what is observed globally.
Downloads
References
Ombelet W, Onofre J. IVF in Africa: what is it all about? Facts Views and Vision in Obstetrics and gynaecology. 2019;11(1):65-76.
Inhorn MC, Patrizio P. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Human Reproduction Update. 2015;21(4):411-426.
WHO. Infertility. Health topics; 2020.
Nachtigall RD. International disparities in access to infertility services. Fertility and sterility. 2006;85(4):871-875.
Adegbola O, Akindele MO. The pattern and challenges of infertility management in Lagos, Nigeria. African Health Sciences. 2013;13(4):1126-1129.
Hörbst V. 'You cannot do IVF in Africa as in Europe': the making of IVF in Mali and Uganda. Reproductive biomedicine & society online. 2016;2:108-115.
Botha B, Shamley D, Dyer S. Availability, effectiveness and safety of ART in sub-Saharan Africa: a systematic review. Human reproduction open. 2018;2018(2):hoy003.
Dadhich P, Ramasamy R, Lipshultz LI. The male infertility office visit. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2015;67(2):157-168.
Katz DJ, Teloken P, Shoshany O. Male infertility - The other side of the equation. Australian family physician. 2017;46(9):641-646.
Winters BR, Walsh TJ. The epidemiology of male infertility. The Urologic clinics of North America. 2014;41(1):195-204.
Carson SA, Kallen AN. Diagnosis and Management of Infertility: A Review. Jama. 2021;326(1):65-76.
Moragianni VA, Penzias AS. Cumulative live-birth rates after assisted reproductive technology. Current Opinion in Obstetrics and Gynecology. 2010;22(3):189-192.
Bosselut H, Paulmyer-Lacroix O, Gnisci A, Bretelle F, Perrin J, Courbiere B. (Prognostic factors of live-birth after in vitro fertilization for unexplained infertility: A cohort study). Gynecologie, obstetrique, fertilite & senologie. 2021; 49(7-8): 601-7.
De Neubourg D, Bogaerts K, Blockeel C, et al. How do cumulative live birth rates and cumulative multiple live birth rates over complete courses of assisted reproductive technology treatment per woman compare among registries? Human Reproduction. 2015;31(1):93-99.
Toftager M, Bogstad J, Løssl K, et al. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols. Human reproduction (Oxford, England). 2017;32(3):556-567.
Copyright (c) 2023 Journal of Infertility and Reproductive Biology

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.